College pushes to sell morning after pill outside pharmacies
A medical college has called for the morning after pill to be reclassified so it can be sold in ordinary retail shops, not just pharmacies. The proposal would put it alongside medicines like paracetamol on general shop shelves. It's a significant ask — one that cuts to the heart of how pharmacy's gatekeeping role is understood by other parts of the healthcare system.
What happened
The college lobbied for the morning after pill to move outside pharmacy-only settings, arguing that broader retail availability would improve access. Under the current arrangement, the pill is sold through pharmacies. The proposed reclassification would allow retailers — shops that are not registered pharmacies — to stock and sell it directly to the public.
The call was reported by Chemist+Druggist. No timeline for any regulatory decision has been confirmed.
Why it matters
This proposal is a direct challenge to one of pharmacy's established access points. Emergency hormonal contraception sits in a category of medicines that the profession has long argued requires a pharmacist to be involved — not as a bureaucratic hurdle, but because there are genuine clinical questions a sale might raise. Retail staff in a supermarket or corner shop don't hold that knowledge.
The reclassification debate also isn't new. There have been repeated pushes over the years to widen access to EHC, with proponents arguing that cost, opening hours, and the discomfort some people feel asking a pharmacist are real barriers. The college's position is that removing the pharmacy requirement would close those gaps.
What the debate tends to underplay is what pharmacy actually provides at the point of sale. A pharmacist or their team can flag interactions, check that the person understands what they're taking, and — where relevant — point someone toward a more appropriate option or onward care. Move the sale to a general retailer and that interaction disappears entirely.
For pre-registration candidates, this story is a prompt to think clearly about what the pharmacy profession's contribution to medicine supply actually is, and how to explain it. When the argument for removing pharmacist involvement is framed around access and convenience, the counter-argument has to be specific, not defensive.
GPhC exam relevance
The GPhC assessment doesn't test current affairs directly, but it does test your understanding of how medicines are classified and what different classifications require at the point of supply. Emergency hormonal contraception is a well-established example of a pharmacy medicine — understanding what that classification means in practice, and why it exists, is fair territory for the exam.
The broader principle matters too. Papers regularly include scenarios where you have to decide whether a sale is appropriate, what information a patient needs, and when to refer. EHC is a common teaching example precisely because it brings those questions together cleanly.
If you haven't already, map out the legal categories for medicine supply — general sale list, pharmacy medicines, prescription-only medicines — and be clear on what each one requires from a pharmacy perspective. That framework is tested, and this story is a good prompt to revisit it.
What's next
No regulatory body has announced a formal review in response to this call. For now, the status of EHC as a pharmacy medicine remains unchanged.
Watch for any MHRA or government response. Reclassification requests follow a formal process, and a college lobbying publicly is an early step, not a decision. If this moves forward, it will surface again before any change takes effect.
For your own preparation, use this as a revision prompt. Be clear on what pharmacy medicines require at the point of supply, and be ready to explain — not just state — why pharmacist involvement has clinical value.
Source: Chemist+Druggist — https://www.chemistanddruggist.co.uk/news/college-calls-for-morning-after-pill-to-be-sold-outside-of-pharmacies-KSMVEU6J5VH6DGNHAID4ELYFOE/